COPD and heart failure: a dangerous duo under the microscope

NCT ID NCT07375433

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how often heart failure with preserved ejection fraction (HFpEF) occurs in people with COPD and how it affects their health over time. Researchers will follow 200 adults aged 50–70 in Russia who are hospitalized with COPD. They will use heart and lung tests to check for hidden heart failure and track deaths, hospital readmissions, and major heart events. No new treatments are being tested—the goal is simply to learn more about the link between these two conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better identify and manage heart failure in people with COPD, potentially improving care.
What could go wrong
This is an observational study, so it won't test any new treatment. Results may not apply to all COPD patients, and findings might not change current practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kazan State Medical University

    RECRUITING

    Kazan', Russia

  • National Medical Research Center for Therapy and Preventive Medicine

    RECRUITING

    Moscow, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.